• Featured
• Most Viewed
• Most Recent
• Most Comments

• AdvaMed2008 - (57)
• Aesthetics - (2)
• Cancer - (1)
• Cardiology - (8)
• Diabetes - (1)
• Diagnostics - (1)
• DrugDelivery - (3)
• European Tech Tour 2008 - (2)
• Health Tech Investment Fo... - (1)
• HIV / AIDS - (1)
• Imaging - (3)
• In3 East-Boston - (16)
• Infectious Disease - (1)
• OMP Financial Forum 2009 - (2)
• Oncology - (1)
• OneMedForum2010 - (1)
• Ophthalmology - (3)
• Orthopedics - (12)
• Other - (9)
• Pain Management - (3)
• Pediatrics - (1)
• Pharmaceuticals - (2)
• Prostate - (4)
• Pulmonology - (1)
• Raw Interviews - (1)
• Resources - (30)
• Urology - (17)
• Venture Fund - (3)

•  

Peter J. Neumann, ScD, director center for the evaluation of value and risk in health Tufts University Stephen J. Northrup, principal Podesta Group trends comparative effectiveness research CER cost-effectiveness analysis CEA Robert J. Rubin healthcare policies reimbursement medical technologies Medicare 2010 InHealth Health Technology Summit Washington, DC resources Marcel Wijma President CEO Van Leeuwenhoeck Research (US) Inc. Corporation OneMedForum New York 2010 resources omfny2010 omfny10 omfny OneMedForum2010 OneMedForum 2010 Senesco Presentation san francisco 2010 OneMedForum genetics diagnostics Tomas J. Philipson, PhD, Daniel Levin Professor of Public Policy Studies, University of Chicago, comparative effectiveness research, public research funding, Medicare, Medicaid, CATIE trial, antipsychotic drugs, heterogeneity in treatment effects, personalized medicine resources veomed, krinsky, aaron, mdma AugmentRx Medical Inc. Urologix Presentation 2010 OneMedForum onemedforum2010 urology CoreSpine Technologies Curative Biosciences, Inc. PearlDiver pearl diver robin young ceo co-founder value medical records database company healthcareIT information technology resources healthcare OneMedForum2010 OneMedForum 2010 Wafergen presentation OneMedForum San Francisco genetics quantum immunologics, josh coughlin, chuck broes, cancer research, cancer treatment, Athena Feminine Technologies chemotherapy liver cancer EyeMarker Systems, Inc.